| APH | Aphidicolin |
| BLCA | bladder urothelial carcinoma |
| BRCA | breast invasive carcinoma |
| BRCT | BRCA1 C terminus |
| CLOW | claudin-low breast cancer subtype |
| COAD | colon adenocarcinoma |
| DSB | DNA double-strand break |
| ER | oestrogen receptor |
| GO | Gene Ontology |
| HER2 | Human Epidermal Growth Factor Receptor 2 |
| HER2E | Human Epidermal Growth Factor Receptor 2-Enriched Breast Cancer Subtype |
| KM | Kaplan–Meier |
| KIRC | kidney renal clear-cell carcinoma |
| LIHC | liver hepatocellular carcinoma |
| LUAD | lung adenocarcinoma |
| LumA | Luminal A breast cancer subtype |
| LumB | Luminal B breast cancer subtype |
| LUSC | squamous cell lung cancer |
| NSCLC | non-small cell lung cancer |
| PAM50 | Prediction Analysis of Microarray 50 |
| PR | progesterone receptor |
| PRAD | prostate adenocarcinoma |
| PSI | percent spliced in |
| TCGA | The Cancer Genome Atlas |
| THCA | thyroid carcinoma |